Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Cardiol Therapeutics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 20 | 34 | +14 |
| Shares | 2.64M | 6.82M | +4.19M (+158.9%) |
| Value | $12.0M | $13.1M | +$1.11M (+9.2%) |
New holders (15)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MMCAP International Inc. SPC | 3,153,200 | $5.83M | 0.36% |
| Verition Fund Management LLC | 457,732 | $847.0K | 0.01% |
| Two Sigma Investments, LP | 194,554 | $360.0K | 0.00% |
| Citadel Advisors LLC | 177,069 | $328.0K | 0.00% |
| Sabby Management, LLC | 99,440 | $184.0K | 0.05% |
| Belvedere Trading LLC | 27,032 | $49.0K | 0.01% |
| Brookstone Capital Management | 15,887 | $27.0K | 0.00% |
| Two Sigma Securities, LLC | 11,280 | $21.0K | 0.00% |
| TD Waterhouse Canada Inc. | 6,900 | $15.8K | 0.00% |
| UBS Group AG | 5,367 | $10.0K | 0.00% |
| Valley National Advisers Inc | 5,000 | $9.00K | 0.00% |
| Commons Capital, LLC | 2,500 | $5.00K | 0.00% |
| City State Bank | 825 | $2.00K | 0.00% |
| Cutler Group LP | 6 | $0 | 0.00% |
| KRS Capital Management, LLC | 100 | $0 | 0.00% |
Sold out (1)
Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Piscataqua Savings Bank | 1,000 | $4.00K |